> top > docs > PubMed:27172902 > spans > 167-425 > annotations

PubMed:27172902 / 167-425 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T2 0-258 Sentence denotes Although many advantageous roles of cisplatin (cis-diamminedichloroplatinum (II), CDDP) have been reported in cancer therapy, the immunomodulatory roles of cisplatin in the phenotypic and functional alterations of dendritic cells (DCs) are poorly understood.

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
11284 36-45 ChemicalEntity denotes cisplatin MESH:D002945
11285 47-75 ChemicalEntity denotes cis-diamminedichloroplatinum MESH:D002945
11286 82-86 ChemicalEntity denotes CDDP MESH:D002945
11287 110-116 DiseaseOrPhenotypicFeature denotes cancer MESH:D009369
11288 156-165 ChemicalEntity denotes cisplatin MESH:D002945

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 110-116 DiseaseOrPhenotypicFeature denotes cancer 0004992

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T9 9-13 GeneOrGeneProduct denotes many
T10 36-45 GeneOrGeneProduct denotes cisplatin
T11 77-79 GeneOrGeneProduct denotes II
T12 156-165 GeneOrGeneProduct denotes cisplatin
T13 224-229 GeneOrGeneProduct denotes cells

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T5 36-45 GeneOrGeneProduct denotes cisplatin
T6 156-165 GeneOrGeneProduct denotes cisplatin

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 110-116 DiseaseOrPhenotypicFeature denotes cancer D009369

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 231-234 DiseaseOrPhenotypicFeature denotes DCs 0010155

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 110-116 DiseaseOrPhenotypicFeature denotes cancer D009369

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 110-116 DiseaseOrPhenotypicFeature denotes cancer D009369

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T2 36-45 ChemicalEntity denotes cisplatin D002945|http://purl.obolibrary.org/obo/CHEBI_27899
T4 47-75 ChemicalEntity denotes cis-diamminedichloroplatinum http://purl.obolibrary.org/obo/CHEBI_27899
T5 82-86 ChemicalEntity denotes CDDP http://purl.obolibrary.org/obo/CHEBI_27899
T6 156-165 ChemicalEntity denotes cisplatin D002945|http://purl.obolibrary.org/obo/CHEBI_27899

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 47-50 OrganismTaxon denotes cis

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T6 156-165 ChemicalEntity denotes cisplatin http://purl.obolibrary.org/obo/CHEBI_27899|D002945
T5 82-86 ChemicalEntity denotes CDDP http://purl.obolibrary.org/obo/CHEBI_27899
T4 47-75 ChemicalEntity denotes cis-diamminedichloroplatinum http://purl.obolibrary.org/obo/CHEBI_27899
T2 36-45 ChemicalEntity denotes cisplatin http://purl.obolibrary.org/obo/CHEBI_27899|D002945
T47382 110-116 DiseaseOrPhenotypicFeature denotes cancer D009369
T44809 47-50 OrganismTaxon denotes cis

Inflammaging

Id Subject Object Predicate Lexical cue
T2 0-258 Sentence denotes Although many advantageous roles of cisplatin (cis-diamminedichloroplatinum (II), CDDP) have been reported in cancer therapy, the immunomodulatory roles of cisplatin in the phenotypic and functional alterations of dendritic cells (DCs) are poorly understood.
T2 0-258 Sentence denotes Although many advantageous roles of cisplatin (cis-diamminedichloroplatinum (II), CDDP) have been reported in cancer therapy, the immunomodulatory roles of cisplatin in the phenotypic and functional alterations of dendritic cells (DCs) are poorly understood.